electroCore (ECOR) Change in Account Payables (2018 - 2026)
electroCore's (ECOR) quarterly Change in Account Payables came in at -$650000.0 in Q1 2026, down 965.57% year-on-year from $75094.7 in Q1 2025, and down 140.7% quarter-over-quarter from $1.6 million in Q4 2025.
electroCore (ECOR) Change in Account Payables (2018 - 2026) Analysis & Trends
electroCore's Change in Account Payables history runs 9 years deep, the most recent figure standing at -$650000.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 965.57% year-over-year to -$650000.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 124.76% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, up 133.78% from the prior year.
- Change in Account Payables retreated to -$650000.0 in Q1 2026 per ECOR's latest filing, from $1.6 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.6 million in Q4 2025 and bottomed at -$869000.0 in Q4 2023.
- The 5-year median for Change in Account Payables is $159000.0 (2024), against an average of $239647.1.
- Across the five-year window, Change in Account Payables surged 2062.5% in 2022 and sank 965.57% in 2026, its largest moves.
- Year by year, Change in Account Payables stood at $228000.0 in 2022, then slumped by 481.14% to -$869000.0 in 2023, then soared by 210.93% to $964000.0 in 2024, then surged by 65.66% to $1.6 million in 2025, then plunged by 140.7% to -$650000.0 in 2026.
- Per Business Quant, the three latest ECOR Change in Account Payables figures stand at -$650000.0 (Q1 2026), $1.6 million (Q4 2025), and $139000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | electroCore | 56,941.08 | -8.77 Mn | 8.36 Mn | -650,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -650,000.00 |
| Mar 31, 2026 | -650,000.00 |
| Dec 31, 2025 | 1.60 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 139,000.00 |
| Sep 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 775,000.00 |
| Jun 30, 2025 | 775,000.00 |
| Mar 31, 2025 | -61,000.00 |
| Mar 31, 2025 | -61,000.00 |
| Dec 31, 2024 | 964,000.00 |
| Dec 31, 2024 | 964,000.00 |
| Sep 30, 2024 | -215,000.00 |
| Sep 30, 2024 | -215,000.00 |
| Jun 30, 2024 | 140,000.00 |
| Jun 30, 2024 | 140,000.00 |
| Mar 31, 2024 | 159,000.00 |
| Mar 31, 2024 | 159,000.00 |
| Dec 31, 2023 | -869,000.00 |
| Dec 31, 2023 | -869,000.00 |